Skip to main content
. 2020 Feb 13;18:76. doi: 10.1186/s12967-020-02232-z

Table 3.

Adverse events occurred in three treatment group

Tianzhi (n = 232) Donepezil (n = 233) Placebo (n = 55)
n (%) n (%) n (%)
Total 4 (1.72) 3 (1.29) 1 (1.82)
Diarrhea 0 1 0
Urinary tract Infection 2 0 0
Insomnia 0 0 1
Abnormal renal function 1 0 0
Arrhythmia 0 1 0
Loss of appetite 0 1 0
Bloating 1 0 0